1
2
Mar. 8, 2021 — A new substance could improve the treatment of persistent cancers. Researchers have developed a new inhibitor that makes drug-resistant tumor cells respond again to chemotherapy. The new substance ...
Jan. 26, 2022 — New research suggests that chemotherapy could better target brain tumors in mouse models when it was administered at night instead of during the day. That's because the blood-brain barrier was ...
Sep. 4, 2023 — Scientists have discovered two new genes that cause head and neck cancer patients to be resistant to chemotherapy, and that silencing either gene can make cancer cells previously unresponsive to ...
Oct. 2, 2023 — A team of researchers has discovered that dormant tumor cells surviving chemotherapy can be targeted through the inhibition of a specific protein called P-glycoprotein (P-gp). This discovery opens up ...
Mar. 10, 2022 — New research has identified that the frequently used chemotherapy drug (5-FU or Fluorouracil) is 100 per cent more effective at targeting tumors (rather than surrounding tissues) when administered ...
Jan. 20, 2022 — A study has found that patients with cancer who receive chemotherapy -- and some targeted therapies, such as CDK4/6 inhibitors and therapies targeted at B cells -- may mount an inadequate immune ...
Jan. 10, 2023 — Researchers have found a new method that within hours can predict if certain cancer patients will survive after ...
Dec. 31, 2020 — A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be ...
Oct. 19, 2021 — Researchers have discovered a new way to jump-start the immune system to attack tumors, which could allow cancer immunotherapy to be used against more types of ...
Mar. 3, 2023 — Cancer cells have an innate randomness in their ability to respond to chemotherapy, which is another tool in their arsenal of resisting treatment, new research ...
